{"id":45159,"date":"2022-06-16T15:01:37","date_gmt":"2022-06-16T13:01:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\/"},"modified":"2022-06-16T15:01:37","modified_gmt":"2022-06-16T13:01:37","slug":"welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\/","title":{"rendered":"Welldoc Granted 31st Patent for First-in-Class Chronic Care Platform"},"content":{"rendered":"
\n

COLUMBIA, Md.–(BUSINESS WIRE)–Welldoc\u00ae, a digital health leader revolutionizing chronic care, today announced that the company\u2019s 31st<\/sup> patent was granted on June 14, 2022, demonstrating the continued advancement of Welldoc\u2019s first-in-class technology for comprehensive chronic condition management. Welldoc\u2019s portfolio includes patents from the U.S. Patent and Trademark Office and IP Australia.\n<\/p>\n

<\/a><\/p>\n

\n\u201cThe expansion of Welldoc\u2019s IP portfolio to thirty-one patents for our platform reinforces our position as a pioneer in the development of digital health solutions for chronic care,\u201d said Kevin McRaith, President and CEO of Welldoc. \u201cGiven the continued advancement in device technology and real-time data capabilities, there is an increased need for connected care solutions which aggregate, translate and visualize large sets of data into meaningful, personalized insights. Welldoc\u2019s early seminal patent filings have enabled us to leverage and adapt our existing technology for use in these modern applications.\u201d\n<\/p>\n

\nThese latest additions to Welldoc\u2019s patent portfolio will support the advancement of the company\u2019s technology designed to optimize clinical decision support across diabetes, hypertension, heart failure and behavioral health. Welldoc currently has patents granted in the U.S. and Australia, with applications pending in the U.S., Europe, Asia, Australia and Canada.\n<\/p>\n

\nWelldoc\u2019s flagship product, BlueStar\u00ae, is an FDA-cleared digital health platform that provides users with the personalized feedback needed to take control of their diabetes management. By analyzing historical data and decision patterns, BlueStar offers real-time coaching designed to shape behaviors including food, activity and medication use with the goal of improving users\u2019 total health.\n<\/p>\n

\nAbout Welldoc\u00ae<\/b>\n<\/p>\n

\nWelldoc\u00ae, a digital health leader revolutionizing chronic care, is integrating personalized, real-time and actionable insights into the daily lives of individuals living with chronic conditions, enabling improved health and outcomes. Welldoc\u2019s comprehensive chronic care platform provides multi-condition support across diabetes, hypertension, heart failure and behavioral health. Welldoc\u2019s flagship product, BlueStar\u00ae, an FDA-cleared digital health solution, guides individuals through the complicated journey of living with diabetes by enabling them to self-manage their care while enhancing connections to their healthcare team. Welldoc partners with health plans, health systems and employers with the goal of extending care, improving health and reducing costs. For more information, visit www.welldoc.com<\/a>. Follow us on LinkedIn and Twitter.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMacDougall
\n
Megan Prock McGrath
\n
781-235-3060
\n
mmcgrath@macdougall.bio<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

COLUMBIA, Md.–(BUSINESS WIRE)–Welldoc\u00ae, a digital health leader revolutionizing chronic care, today announced that the company\u2019s 31st patent was granted on June 14, 2022, demonstrating the continued advancement of Welldoc\u2019s first-in-class technology for comprehensive chronic condition management. Welldoc\u2019s portfolio includes patents from the U.S. Patent and Trademark Office and IP Australia. \u201cThe expansion of Welldoc\u2019s IP … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45159","6":"format-standard","7":"category-industry"},"yoast_head":"\nWelldoc Granted 31st Patent for First-in-Class Chronic Care Platform - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Welldoc Granted 31st Patent for First-in-Class Chronic Care Platform - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"COLUMBIA, Md.–(BUSINESS WIRE)–Welldoc\u00ae, a digital health leader revolutionizing chronic care, today announced that the company\u2019s 31st patent was granted on June 14, 2022, demonstrating the continued advancement of Welldoc\u2019s first-in-class technology for comprehensive chronic condition management. Welldoc\u2019s portfolio includes patents from the U.S. Patent and Trademark Office and IP Australia. \u201cThe expansion of Welldoc\u2019s IP ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-16T13:01:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220616005161\/en\/1488172\/21\/Welldoc_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Welldoc Granted 31st Patent for First-in-Class Chronic Care Platform\",\"datePublished\":\"2022-06-16T13:01:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\\\/\"},\"wordCount\":391,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220616005161\\\/en\\\/1488172\\\/21\\\/Welldoc_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\\\/\",\"name\":\"Welldoc Granted 31st Patent for First-in-Class Chronic Care Platform - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220616005161\\\/en\\\/1488172\\\/21\\\/Welldoc_logo.jpg\",\"datePublished\":\"2022-06-16T13:01:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220616005161\\\/en\\\/1488172\\\/21\\\/Welldoc_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220616005161\\\/en\\\/1488172\\\/21\\\/Welldoc_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Welldoc Granted 31st Patent for First-in-Class Chronic Care Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Welldoc Granted 31st Patent for First-in-Class Chronic Care Platform - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\/","og_locale":"en_US","og_type":"article","og_title":"Welldoc Granted 31st Patent for First-in-Class Chronic Care Platform - Pharma Trend","og_description":"COLUMBIA, Md.–(BUSINESS WIRE)–Welldoc\u00ae, a digital health leader revolutionizing chronic care, today announced that the company\u2019s 31st patent was granted on June 14, 2022, demonstrating the continued advancement of Welldoc\u2019s first-in-class technology for comprehensive chronic condition management. Welldoc\u2019s portfolio includes patents from the U.S. Patent and Trademark Office and IP Australia. \u201cThe expansion of Welldoc\u2019s IP ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-16T13:01:37+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220616005161\/en\/1488172\/21\/Welldoc_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Welldoc Granted 31st Patent for First-in-Class Chronic Care Platform","datePublished":"2022-06-16T13:01:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\/"},"wordCount":391,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220616005161\/en\/1488172\/21\/Welldoc_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\/","url":"https:\/\/pharma-trend.com\/en\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\/","name":"Welldoc Granted 31st Patent for First-in-Class Chronic Care Platform - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220616005161\/en\/1488172\/21\/Welldoc_logo.jpg","datePublished":"2022-06-16T13:01:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220616005161\/en\/1488172\/21\/Welldoc_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220616005161\/en\/1488172\/21\/Welldoc_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/welldoc-granted-31st-patent-for-first-in-class-chronic-care-platform\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Welldoc Granted 31st Patent for First-in-Class Chronic Care Platform"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45159","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45159"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45159\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45159"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45159"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45159"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}